Patient reported symptoms associated with quality of life during chemo- or immunotherapy for bladder cancer patients with advanced disease.

ABSTRACT:

Background

Bladder cancer (BC) patients with advanced disease have poor outcomes. The use of patient-reported outcomes (PROs) could lead to improvements in symptom management and hence quality of life (QoL). The aim of this study is to report correlations between selected PROs and QoL and thus to present symptoms that influence QoL. Identification of these symptoms during treatment can lead to earlier symptom management and thus secure improvements in QoL.

Methods

BC patients in chemo- or immunotherapy for locally advanced or metastatic disease reported weekly PROs for the duration of their treatment. The PROs included EORTC QLQ-C30 and QLQ-BLM30 and 45 selected PRO-CTCAE items. Spearman's correlation analysis was performed for all PRO-CTCAE items and QLQ-C30 global QoL and

SUBMITTER: Taarnhoj GA 

PROVIDER: S-EPMC7196058 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature